Sep 07, 2017, 07:00 ET
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its identifier (NCT number): NCT02278120
Show 204 Study Locations
Sponsors and Collaborators Novartis Pharmaceuticals Investigators Study Director: Novartis Pharmaceuticals Novartis Pharmaceuticals More Information
Responsible Party: Novartis Pharmaceuticals Identifier: NCT02278120 History of Changes Other Study ID Numbers: CLEE011E2301
First Submitted: October 22, 2014 First Posted: October 29, 2014 Last Update Posted: July 11, 2017 Last Verified: July 2017 Individual Participant Data (IPD) Sharing Statement: Plan to Share IPD: Undecided Plan Description: Novartis is committed to sharing with qualified external researchers, access to patient-level data and supporting clinical documents from eligible studies. These requests are reviewed and approved by an independent review panel on the basis of scientific merit. All data provided is anonymized to respect the privacy of patients who have participated in the trial in line with applicable laws and regulations.